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Noelins comprise a family of extracellular proteins with proposed roles in neural and neural crest development. Here, we show that a previously
uncharacterized family member, Noelin-4, functions to maintain neural precursors in an undifferentiated state and biases ectoderm toward a neural
fate. We show thatNoelin-4 is induced by the neurogenic genes X-ngnr-1 and XNeuroD. Over-expression ofNoelin-4 causes expansion of the neural
plate at the expense of neural crest and epidermis. Although there is an apparent increase in the neural precursor pool, no increase was noted in
differentiated neurons. Later, derivatives such as the neural tube and retina appear enlarged. We show biochemically that Noelin-4 protein is
glycosylated and secreted and that it interacts with Noelin-1, an isoform previously found to promote differentiation in neuralized animal caps.
Accordingly, the neural precursor expansion activity ofNoelin-4 is reversed by co-expression ofNoelin-1. Our finding thatNoelin isoforms can bind
to and antagonize one another suggests that interacting Noelin isoforms may play a role in regulating timing of differentiation.
D 2005 Elsevier Inc. All rights reserved.Keywords: Noelin-4; Noelin-1; Neurogenesis; Xenopus; Neural competence; Neural differentiationIntroduction
Neural development is a complex process that requires the
activities of many opposing and cooperative gene networks
and signaling pathways. In Xenopus, neural development
begins during gastrulation when the dorsal mesoderm signals
the overlying ectoderm to become neural (Chang and
Hemmati-Brivanlou, 1998; Harland, 2000; Sasai and De
Robertis, 1997; Weinstein and Hemmati-Brivanlou, 1999).
First, a broad neural domain is established, characterized by
expression of early response genes (Turner and Weintraub,
1994; Ferreiro et al., 1994; Kroll et al., 1998; Mizuseki et al.,
1998a,b). Subsequently, neurogenesis is activated by a
cascade of bHLH transcription factors, typified by the
proneural and neurogenic genes X-ngnr-1 and XNeuroD
(Lee et al., 1995b; Ma et al., 1996), that determine which
cells give rise to neurons within the field of cells with neural
potential. Later-expressed factors influence specification and
differentiation of neuronal subtypes. Many transcriptional0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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CA 92037, USA.regulators of these events have been characterized, but less is
known about downstream components that mediate the
process of neuronal differentiation.
Noelins are a family of secreted glycoproteins that have
been implicated in both neural crest development and
neurogenesis (Barembaum et al., 2000; Kulkarni et al.,
2000). Four different Noelin isoforms are formed by
differential promoter usage and alternative splicing (Daniel-
son et al., 1994; see Fig. 1A): Noelin-1 (BMZ), Noelin-2
(AMZ), Noelin-3 (BMY) and Noelin-4 (AMY) from the five
available exons, A, B, M, Y and Z (Barembaum et al., 2000;
Danielson et al., 1994). These genes are part of a larger family
of proteins containing an ‘‘olfactomedin domain,’’ although
Noelin-3 and -4 lack the exon that encodes this domain. The
expression patterns of some of the Noelin isoforms have been
described in mouse, rat, Xenopus and chick (Barembaum et al.,
2000; Kondo et al., 2000; Moreno and Bronner-Fraser, 2001,
2002; Nagano et al., 1998, 2000). In early development,
Noelins are expressed in the neural plate of chick and mouse;
later, they resolve to the neural folds and migrating neural crest
cells. In contrast, Xenopus Noelin-1 is expressed after neural
tube closure, and only in postmitotic neuronal cells. Postnatal-
ly, Noelins are expressed in the cortex of mouse brain (Nagano
et al., 1998). Some functional studies have been undertaken to88 (2005) 434 – 447
www.e
Fig. 1. Schematic diagram of Noelin isoform exon composition. (A) Noelins are made by differential promoter usage and alternative splicing. Exon structure was first
elucidated in the rat by Danielson et al. (1994). The olfactomedin domain is indicated, as well as the location of the two cysteine residues conserved in all Noelins
and homologous to cysteines in Olfactomedin that are responsible for disulfide bonding in multimerization (asterisks in M region). (B) Noelin exon terminology used
in this work is shown, with predicted signal peptide cleavage sites indicated with arrowheads.
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chick, Noelin-1 was shown to increase the competence of the
neural tube to produce neural crest cells, while in Xenopus,
Noelin-1 promotes neuronal differentiation (Barembaum et al.,
2000; Moreno and Bronner-Fraser, 2001). Although the
function of Noelin-1 has been characterized in these species,
nothing is known about the function of Noelin-4.
In the present study, we explore the role of Noelin-4 in
Xenopus development and provide evidence for a unique
function as a factor that maintains neural precursors in an
undifferentiated state. Embryos injected with Noelin-4 mRNA
exhibit enlargement of neural precursor territories and later have
enlarged retinas and ectopic neural structures resembling
ganglia, otic vesicles and cement glands. This expansion of
neural plate occurs apparently at the expense of neural crest and
epidermis. Strikingly, the neural-expansion promoting activity
of Noelin-4 is reversed by co-expression of Noelin-1, to which it
binds in co-immunoprecipitation assays. The overlapping
expression pattern of Noelin isoforms, together with the
biochemical and functional interactions of the Noelin-1 and -4
proteins, suggest a role for competitive Noelin interactions in
regulating the timing of differentiation in the cells in which they
are expressed.
Materials and methods
Library screening and cDNA isolation
A stage 28 phage cDNA library in Lambda ZapII made from head tissues was
kindly provided by Dr. R. Harland (Hemmati-Brivanlou et al., 1991). Full-length
clones of Noelin-1, -2 and -4 were obtained after low-stringency screening using
chick Noelin-1 as a probe. Sequences were compiled and edited using the
DNAStar programs. Sequences comparisons were performed using BLAST
(Altschul et al., 1990). Signal peptide prediction was done by a computer
modeling method on the server http://www.cbs.dtu.dk/services/signalP (Nielsen
et al., 1997).
Noelin-3 (encoded by exons BMY) was assembled from existing clones of
Noelin-1. The B and M exons were amplified by PCR with the following oligos:
upstream: 5V-CCA TCG ATC CAA GCA AAC ATG TCT GTG CC-3V, and
downstream: 5V-AGG CAG TTT AAG GGC TGA ATT CCG-3V, these were
cloned into pCS2+ (Rupp et al., 1994; Turner and Weintraub, 1994). Thedownstream oligo is complementary to the last 12 bases of the M exon, with an
added glycine residue and stop codon (Y exon sequences).
Xenopus laevis embryo and oocyte manipulations
Xenopus embryos were obtained by in vitro fertilization using eggs from
pigmented and albino females and testis from pigmented males, according to
established methods (Sive et al., 2000). Embryos were staged according to the
normal tables of (Nieuwkoop and Faber, 1967).
Animal caps were manually isolated from stage 8 to 9 blastulae and
cultured in 3/4  NAM (Slack and Forman, 1980) until siblings reached the
stage indicated, when they were processed for RT-PCR.
Stage VI oocytes were manually defolliculated in OR2 and allowed to
recover for one day before injection.
Microinjections
For oocytes: capped messenger RNA was transcribed in vitro (Sive et al.,
2000) and up to 2 ng was injected per oocyte in a volume of up to 20 nl.
Injected oocytes were cultured in OR2 medium supplemented with 1 mg/ml of
BSA (Sigma), Gentamycin and 10 ACi of [35S]-methionine (Express Protein
Labeling Mix, NEN) in a total volume of 200 Al. Injected oocytes were cultured
for 24 h. All samples were run in duplicate or triplicate for each experiment.
For embryos: capped messenger mRNA was transcribed as above, or by
using the mMessage mMachine SP6 kit (Ambion). Varying concentrations were
injected in volumes ranging from 5 to 10 nl at the two-cell stage, into both
blastomeres for animal cap experiments, into one cell of two for whole embryo
experiments, or 5 nl into 32-cell-stage blastomeres. X-ngnr-1 was injected at
100 pg per embryo; XNeuroD was injected at 500 pg per embryo, noggin at
100 pg per embryo. Noelin isoforms were injected at a range from 50 pg to 1.5
ng as indicated in the text.
Embryos injected with lacZ were stained for h-galactosidase activity with
X-Gal (Roche) or Magenta Gal (Biosynth).
Immunoprecipitations and Western blots
Oocyte and supernatant fractions were collected from duplicate samples
containing 5 oocytes injected with the indicated mRNAs and cultured for
24 h. In vitro-translated protein was synthesized using the same mRNAs in
Nuclease-treated Rabbit Reticulocyte Lysate (Promega) according to the
manufacturer’s instructions. Anti-myc antibody (mouse monoclonal antibody
9E10, Santa Cruz Biotechnology) was used at 1:500. Anti-flag M2
antibody (mouse monoclonal, Sigma) was used at 10 Ag/ml. Samples were
incubated with Protein A Sepharose (Sigma) to immunoprecipitate the
antibody-bound proteins. Samples were run out on 14% SDS-PAGE gels
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performed using Enhanced Chemiluminescence (ECL, Pharmacia). Enzy-
matic deglycosylation was performed according to manufacturer’s instruc-
tions (PNGase F, NEB).
In situ hybridization and immunohistochemistry
In situ hybridization was performed as described (Knecht et al., 1995). For
immunohistochemistry, anti-phospho-histone H3 (rabbit IgG, Upstate Tech-
nologies) was diluted to 1:200. The antibody was detected with HRP-conjugated
goat anti-rabbit IgG (Molecular Probes) at 1:400. For sectioning, embryos were
embedded in Paraplast Plus wax and sectioned on a Leitz microtome at 10 Am.
Sectioned whole mount in situs were counterstained in Light Green SF (Sigma).
For TUNEL staining, embryos were incubated with 0.5 AMdigoxygenin-labeled
dUTP (Roche) and 150 U/ml Terminal deoxynucleotidyltransferase (Invitrogen)
in 1 TdT buffer overnight at room temperature, stopped in PBS + 1 mM EDTA
at 65-C, followed by washes in PBS and detection as for in situ hybridization.
RT-PCR analysis
RT-PCR analysis was as described (Moreno and Bronner-Fraser, 2001) on
pools of total RNA from 2 embryos or 10 animal caps. First strand synthesis was
performed with Superscript III Reverse Transcriptase (Life Technologies) with
random hexamers (Life Technologies) according to manufacturer’s instructions.
Primers were as described in (Moreno and Bronner-Fraser, 2001) or below. One
third of each PCR reaction was run on a 5% polyacrylamide gel and analyzed
autoradiographically and on the PhosphorImager. Noelin isoform PCR primer
pairs used were: A+Y, A+Z, B+Y, B+Z; each product approx. 330 nt, 30 cycles.
Noelin A: 5V-GCA AGC TGATGA GTC TCT TC-3V; Noelin B: 5V-GGA ACC
TTG GAT AGG AGC-3V; Noelin Y: 5V-TGC CTC TTC AGT CTT TGC-3V;
Noelin Z: 5V-CAA CAC TGG TAT CAG AGG-3V.
Results
Noelin-4 sequence and structure
Noelin isoforms include four splice variants assembled by
differential promoter usage and alternative splicing. XenopusFig. 2. Noelin-4 is a secreted, glycosylated protein. (A) Noelin constructs used in th
terminal. Noelin-4DA-myc is Noelin-4-myc with the A exon removed. (B) Noelin-4-
fractions. In vitro-translated protein (IVT) is shown in lane 3. Oocyte and superna
translated core protein. (BV) Anti-myc Western blot of embryos injected with Noelin-4
SDS-PAGE either as embryo lysate (lane 1), lysate treated with PNGase F (deglyc, l
sample collapsed to the size of in vitro-translated protein. (C) Noelin-4DA-myc
supernatant fraction (lane 2 versus lane 3). Control oocytes and supernatant are shoNoelin-4 contains the A, M, and Y exons, and is the smallest of
the four Noelin splice variants (Fig. 1). The longest open
reading frame from the first start codon (381 bp) encodes a
predicted 126 amino acid (aa) protein with a molecular weight
of approximately 14.7 kilodaltons (kDa). Xenopus Noelin-4 is
89–92% identical at the nucleotide level to previously isolated
rat (GenBank accession number I73636), mouse (pancortin-4,
BAA28764), and human (JC5272) orthologues.
Noelin-4 has several recognizable sequence features includ-
ing one N-linked glycosylation site and two potential hyaluro-
nate binding sites. Noelin-4 also contains two cysteine residues
that are conserved in all Noelin isoforms (Fig. 1A, asterisks) and
that are spatially homologous to two cysteine residues in
olfactomedin. These are thought to be responsible for intermo-
lecular disulfide bonding in that protein (Yokoe and Anholt,
1993). Although Noelin-4 is slightly related to olfactomedin, the
founding member of the olfactomedin domain family (Kulkarni
et al., 2000; Snyder et al., 1991), it lacks the Z exon found in
Noelin-1 and -2 that contains the olfacotmedin domain itself
(Figs. 1A, B). As with Noelin-1 and -2, Noelin-4 has a hydro-
phobic leader sequence that is predicted to be cleaved after
residue #26 in the sequence VLP-TN, removing the entire A
region (arrowheads, Fig. 1B). This leaves essentially the M
region as the mature protein since the Y exon encodes one gly-
cine residue and then a stop codon. This analysis of the sequence
suggests that Noelin-4 may be secreted and glycosylated.
Noelin-4 is a secreted protein
To determine whether Noelin-4 is a secreted protein, we
expressed epitope-tagged constructs in Xenopus oocytes (Fig.
2A). Cellular and supernatant fractionswere immunoprecipitated
and compared (Fig. 2B). Full-length Noelin-4 with a carboxy-ese studies are shown schematically. Noelin-4 was myc-tagged at the carboxy
myc was immunoprecipitated from oocyte (o, lane 1) and supernatant (s, lane 2)
tant fractions contain Noelin-4 protein that is larger than the size of in vitro-
-myc or Noelin-4 (for a Western blot control) as indicated. Proteins were run on
ane 2) or in vitro-translated protein (IVT, lane 3). Proteins in the deglycosylated
immunoprecipitated from the oocyte fraction only, and was not found in the
wn in lanes 4–6.
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supernatant fractions (Fig. 2B, lanes 1 and 2). The presence of
Noelin-4 protein in the supernatant suggests that the hydrophobic
leader sequence was indeed cleaved in vivo, allowing the protein
to be secreted. The size of the oocyte-synthesized Noelin-4
protein was larger than that of the in vitro-translated protein (lane
3), suggesting that the former was glycosylated. In order to test
this possibility, protein samples from Noelin-4-myc injected
embryos were treated with a deglycosylating enzyme. When
treated with PNGase F, the protein detected by anti-myc on a
Western blot collapsed to roughly the size of in vitro-translated
Noelin-4-myc (Fig. 2BV, lanes 2 and 3), while untreated sample
ran more slowly through the gel (Fig. 2BV, lane 1). Together,
these results show that Noelin-4 is a glycosylated protein.
Noelin-4 appears to be more robustly secreted than the
previously characterized Noelin-1 isoform (Moreno and
Bronner-Fraser, 2001). Noelin-1 and -2 contain the carboxy
terminal sequence Ser–Asp–Glu–Leu (SDEL) which is likely
responsible for their less efficient secretion (Moreno andFig. 3. Developmental expression patterns of Noelins. (A) Noelin temporal expressio
presence of the specific Noelin isoforms by RT-PCR. EF1a is a loading control, R
only one splice variant each, as indicated. Noelin expression is observed weakly fr
Spatial expression pattern of Noelin-3/4 (Y exon in situ hybridization, purple staini
cranial ganglia (arrowhead) and spinal cord; (C) stage 29 embryo with staining in t
embryo highlighting olfactory placode expression (arrowhead); (E) dorsal view o
magnification of boxed region in panel D showing neuromast expression (arrowheBronner-Fraser, 2001). This sequence is similar but not
identical to the consensus sequence KDEL signal for protein
retention in the endoplasmic reticulum of vertebrates, Dro-
sophila, C. elegans and plant cells (Munro and Pelham, 1987).
To confirm that the A exon contains a signal sequence for
Noelin-4 secretion, a construct lacking this portion of Noelin-4
(Fig. 2C, DA-myc) was generated (see Fig. 2A for schematic).
Noelin-4DA-myc was synthesized in oocytes (Fig. 2C, lane 2)
but was not secreted (lane 3). In addition, both the in vitro-
translated and the in vivo-synthesized protein were the same
size, indicating that they were not glycosylated (compare lanes
1 and 2). Thus, the A region with its hydrophobic leader
sequence appears to be required for the secretion and thus
glycosylation of Noelin-4.
Noelins are expressed early in development
To determine the temporal expression pattern of Noelin
isoforms in Xenopus, we performed a developmental series ofn patterns. Embryos were harvested at the stages indicated and examined for the
T is a control for genomic DNA contamination. Primer pairs used hybridize to
om neural plate stages, with strong expression from late neurula stages. (B–F)
ng). Anterior is to the left. (B) Side view of stage 27 embryo with staining in
rigeminal ganglion (arrowhead) and spinal cord; (D) anterior view of stage 26
f stage 42 embryo with staining in cranial ganglia, eye, and neuromasts; (F)
ad).
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through late tailbud (stage 31). Oligonucleotides directed to
regions flanking the common central M exon revealed the
temporal distribution of each of the isoforms (Fig. 3A).
Interestingly, the B-containing isoforms, Noelin-1 and Noe-
lin-3, were observed from stage 14 onward, with increasing
expression as development proceeds. The A-containing iso-
forms Noelin-2 and Noelin-4 were present at low levels
through the same stages as the B-containing isoforms, and
may be present at low levels even earlier. Like the B isoforms,
the A isoforms were also strongly expressed by stage 25 (Fig.
3A, lane 5).
Noelin-3 and -4 are expressed in post-mitotic neural tissues
We previously showed that Xenopus Noelin-1 and -2 are
expressed from stage 20 in post-mitotic neural tissues (Moreno
and Bronner-Fraser, 2001). To examine the spatial expression
pattern of Noelin-3 and -4, whole mount in situ hybridization
was performed with several probes from different regions of
the sequences of Noelin-3 (BMY) and Noelin-4 (AMY).
Results with the Y exon probe which marks Noelin-3 and -4
indistinguishably and which we refer to in this context as
Noelin-3/4, are essentially equivalent to those obtained with the
A, B and Z exons (Fig. 3B; Moreno and Bronner-Fraser, 2001,
2002). Expression was observed in post-mitotic neural tissues
in the brain, spinal cord and cranial ganglia beginning at stage
21 (Figs. 3B–F and Moreno and Bronner-Fraser, 2001). At the
latest stage examined, tadpole stage 42, expression was also
observed in neuromasts and lateral line ganglia (Figs. 3E, F).
Thus, the Y-containing Noelin-3/4 isoforms mark post-mitotic
neural cells in both the peripheral nervous system (cranial
ganglia and lateral lines) and the central nervous system (eye,
brain, spinal cord) as do the Z-containing Noelin-1/2 isoforms.Fig. 4. Noelin-3 and -4 are induced by neurogenin. (A, B) Embryos were injected in
Whole mount in situ hybridization for N-tubulin (A) or the Y exon of Noelin-3 and
arrowheads. (C–E) cross-sections of animal caps from embryos injected with 100
Arrows point to regions staining with the markers. (C) N-tubulin staining; (D) Y ex
were derived from pigmented mothers; brown color is due to pigment granules. (F)
injected with lacZ (c, lane 2), X-ngnr-1 (ng, lane 3), or XNeuroD (nd, lane 4), or
expression of all four Noelin isoforms. RNA without reverse transcriptase was used
hybridizes to only the indicated isoform. SybII = synaptobrevinII, a marker for difNoelin-3/4 are induced by neurogenic genes
Neurogenesis is initiated by a neurogenic transcriptional cascade
that activates and promotes neuronal differentiation. Ectopic
expression of neurogenic genes causes neurons to develop in the
epidermis. Since Noelin isoforms are expressed in post-mitotic
neural tissues, we tested whether Noelin-4 and its closely related
splice variant Noelin-3 were activated by the neurogenic cascade.
We observed that Noelin-3/4 were up-regulated in ectopic
neurons induced by both XNeuroD (see Fig. 4F) and X-ngnr-1
(Fig. 4B, arrowhead). In general, all embryos injected with X-
ngnr-1 or XNeuroD displayed this phenotype (for one
representative experiment: 96%, n = 25). Interestingly, N-
tubulin appeared to consistently mark a greater number of
neurons than did the Noelin isoforms suggesting that Noelin
may mark a subset of neurons induced by neurogenic genes
(compare Figs. 4A and B).
We next asked whether neurogenic genes could induce
Noelin-3/4 expression in the absence of mesoderm signals in
animal cap explants. The common Y exon of Noelin-3/4 was
modestly induced in animal caps expressing X-ngnr-1 (Fig.
4D) or XNeuroD (see Fig. 4F). N-tubulin was highly induced
by X-ngnr-1 (Fig. 4C). Control animal caps injected with lacZ
did not express the Y exon (Fig. 4E). These results show that
Noelin-3/4 are induced by genes in the neurogenic cascade,
both in whole embryos and in isolated animal caps, but much
more robustly in the former.
In order to precisely determine which isoforms were
induced by X-ngnr-1 and XNeuroD, we performed RT-PCR
on induced animal caps using primers that specifically target
each isoform (as in Fig. 3). All four isoforms were induced in
animal caps by stage 22 (Fig. 4F), confirming our previous
results that both Noelin A forms and both Noelin B forms are
induced by neurogenic genes.one cell at the two-cell stage with 100 pg of X-ngnr-1 and cultured to stage 24.
-4 (B) is shown. Ectopic neurons staining with the markers are indicated with
pg X-ngnr-1 or lacZ in 2/2 cells, excised at stage 9 and cultured to stage 22.
on staining; (E) lacZ-injected, N-tubulin staining. Embryos for this experiment
RT-PCR on stage 22 animal caps explanted at stage 10, derived from embryos
on whole embryo controls (e, lane 1). Both XNeuroD and X-ngnr-1 induced
as a negative control (, lane 5). Primers used are indicated; each Noelin set
ferentiating neurons (Knecht et al., 1995).
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To examine the possible function of Noelin-4 in the embryo,
we first performed gain-of-function experiments. 85% of
embryos injected with doses of Noelin-4 mRNA ranging from
500 pg to 1 ng exhibited abnormal development of the nervous
system. The majority of embryos displayed enlarged neural
tissues and/or ectopic cement glands and pigment cells. The
observed phenotypes are summarized in Table 1. When embryos
were injected with 500 pg of Noelin-4 mRNA in one blastomere
at the 2-cell stage, therewas a unilateral expansion of neural tissue
(Table 1), manifested as asymmetrical neural plate. Staining with
the pan-neural marker Sox-2 at stage 16 revealed considerable
enlargement of the neural plate on the injected side (Fig. 5A). In
contrast, sibling control embryos injected with Noelin-2 (AMZ)
or lacZ had normal-appearing, symmetric neural plates (Figs. 5B
and C). At later stages, retinas and spinal cords were enlarged on
the injected side (Figs. 5D–G and data not shown).
The Noelin-4-induced expansion of neural territories, espe-
cially in the retina, caused further secondary defects in older
embryos. Normally, the optic vesicles evaginate to form the
optic cup beginning at stage 29. Noelin-4 over-expression often
caused enlargement of the retina in both circumference and
thickness and a delay in evagination (Figs. 5F, G). In addition to
neural/retinal expansion, a high percentage of injected embryos
exhibited a mild axial dorsalization (i.e., reduction of tail
structures, bent axis) and spina bifida (open spinal cord; see
Table 1). There appeared to be loss of ventral/posterior fates with
a concomitant increase in dorsal/anterior fates.
The phenotype after Noelin-4 over-expression was dose-
dependent. At higher doses, an increased frequency and severity
of phenotype was observed, with as many as 50% of embryos
exhibiting enlarged neural structures, failure of neural tube
closure and ectopic development of Sox-2-expressing structures
(n = 185 in five separate experiments; see also Table 1; Fig. 5O).Table 1
Noelin-4 over-expression phenotypes
Phenotype % experimental/
% control
Enlarged retina 38/0
Enlarged neural tube 33/0
Ectopic cement gland 18/0
Ectopic pigment cells 10/0
Retinal pigmented epithelium
extending into midbrain
15/2
Ectopic neural structures 10/0
Spina bifida 41/2
Bifurcated tail 18/0
Disorganized/missing
anterior neural structures
18/0
Normal 15/94
Over-expression phenotypes observed for Noelin-4. Two experiments were
combined (injected embryos n = 100, control embryos n = 50) and data were
tabulated for both. Most embryos displayed multiple phenotypes. Cement
glands, pigment cells, and retinal pigmented epithelium extension were scored
by visual inspection of unstained whole mounts. Enlarged neural tube and
retina, as well as ectopic neural structures, were scored by Sox-2 staining
appearance. Control embryos were injected with similar doses of lacZ mRNA.Frequently, embryos had ectopic cement glands (see Table 1;
Figs. 5M, O) that were discontinuous with the endogenous ones
and always located on the head ectoderm, typically near the eye
or over the branchial arches. The retinal pigmented epithelium
(RPE) sometimes was expanded into the midbrain in embryos
with anterior injections (data not shown) and ectopic, pigmented
Sox-2-positive regions with the appearance of ectopic RPE were
observed (Figs. 5N, O, and see Table 1). By contrast, embryos
injected with the same doses of Noelin-1, Noelin-2 or lacZ
mRNA appeared normal, indicating that these results were
specifically due to the over-expression ofNoelin-4 (see Table 2).
The Noelin-4 over-expression phenotype appears to be
sensitive to the level of Noelin-4 seen by the tissues affected.
The activity of the lineage tracer h-galactosidase indicates an
area of concentration of the injected mRNA; the actual spread
of the injection may be over a much greater area. In our
experiments, lineage tracer-positive cells generally were found
surrounding but not necessarily within ectopic neural, Sox-2-
positive tissue; however, ectopic cement glands always
contained high levels of the lineage marker.
Since we observed an increase in neural precursors, we also
examined whether Noelin-4 over-expression caused an increased
number of neurons to differentiate. Embryos stained with the pan-
neuronal marker N-tubulin did not exhibit any increase in the
number of neurons or any ectopic neuronal differentiation (Figs.
5P–S). Thus, Noelin-4 over-expression causes an increase in the
neural precursor population but does not promote greater numbers
of neurons to differentiate. Interestingly, we observed that in a
modest number of injected embryos (n = 12/50), N-tubulin
expression in the neural plate was reduced in the lateral stripe
containing sensory neuron precursors (compare Figs. 5P and Q).
By later neurula stages, N-tubulin expression recovered and no
decrease was noted (Fig. 5R).
Since changes in the underlying mesoderm could explain the
expansion of the neural tissues, we examined the effects of over-
expressed Noelin-4 on mesoderm. First, we performed RT-PCR on
animal caps from embryos injected with Noelin-4 at doses that
caused severe neural patterning defects. The mesoderm marker
muscle actin (MA) was not induced (Fig. 6A, lane 4). This suggests
that Noelin-4 cannot induce mesoderm to form in this context. We
also determined thatNoelin-4 is not a direct neural inducer (such as
noggin or chordin; Harland, 2000), since it did not induce neural
marker expression in animal caps (NCAM, Fig. 6A, lane 4).
Next, we examined the effects of Noelin-4 injection on
mesoderm in whole embryos. Cross-sections through all axial
levels revealed no specific deformities in the developing
mesoderm (see Fig. 5). In situ hybridization for MA, which
marks paraxial mesoderm, failed to show obvious changes in
MA in the mesoderm (Figs. 6B, C). Thus, the neural patterning
defects caused by Noelin-4 cannot be attributed to changes in
the underlying mesoderm.
Noelin-4-induced neural expansion is not mediated by
increased proliferation or loss of cell death
Two possible explanations for the neural expansion ob-
served after over-expression of Noelin-4 are that there was an
Fig. 5. Noelin-4 over-expression results in expansion of neural fate. Embryos injected with Noelin-4 exhibit enlarged and ectopic neural tissue. Embryos were
injected with 500 pg (A–G, P–S) or 1 ng (H–O) of Noelin-4 mRNA, 500 pg Noelin-3 (T, U), and 100 pg of lacZ mRNA as a lineage tracer. h-galactosidase activity
was assessed with X-gal (turquoise, A–G) or Magenta-Gal (magenta, H–O) and embryos were stained for Sox-2 expression. (A–C) Neural plate stage embryos
injected with (A) Noelin-4 (AMY), (B) Noelin-2 (AMZ) or (C) lacZ. Injected side is to the left, embryos are photographed from the dorsal side, oriented with
anterior pointing up. Anterior neural plate is indicated with an arrowhead. Note expansion of the neural plate in panel A. (D–G) Embryos were harvested at stage 29
and stained for Sox-2 expression. (D) Control side, (E) injected side of same embryo. Neural retina is revealed by Sox-2 staining, note that injected side eye is larger
than control side (arrowheads). (F) Cross section through midbrain region; (G) comparison of neural retinas from both sides of the embryo magnified to the same
degree. (H–O) Examples of embryos harvested at stage 35 and stained for Sox-2 expression. (H, L) Control side; (I, M) injected side. Panels J, N, and O are cross-
sections through the head regions with the section level indicated on panels I and M. Panel K is a magnification of the injected side in panel J. Note expansion of
neural tissue and ectopic Sox-2 staining (arrowhead). Panel O shows an ectopic cement gland ventral to the eye (arrow) that is discontinuous with the endogenous
cement gland (see arrowhead in panel M). (P–S) N-tubulin staining of embryos injected with Noelin-4 (P, R) or Noelin-1 (Q, S). (P, Q) Neural plate stage embryos,
with injected side to the left, anterior pointing to top. (R, S) Embryos at stage 24 with anterior to the left. Arrowheads indicate bulging tissue on the injected side in
panels P, R. (T, U) Noelin-3 causes similar neural territory expansion. Noelin-3 (BMY) injection, Sox-2 staining. Bars and brackets outline width of neural structures
in two different embryos on the injected side (bottom half) and uninjected control side (top half).
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Table 2
Noelin-1 rescues Noelin-4 phenotype
Phenotype N4 (high) N4 + N1 (high:high) N1 (high) N4 (low) N4 + N1 (low:high)
Ectopic cement gland 32% 6% 0 5% 0%
Enlarged neural tissue 50% 15% 0 51% 18%
Severity *** ** n/a ** *
Spina bifida 26% 3% 0 3% 3%
Number of embryos 50 34 67 37 40
Co-expression phenotypes of Noelin-1 and Noelin-4. Noelin-1 and/or Noelin-4 mRNAs were injected as indicated, with relative doses of 1:3 or 1:1 (RNA: water or
co-expressed RNA) by RNA concentration. Embryos were scored visually at stage 31. N1 = Noelin-1, N4 = Noelin-4. Injection of equivalent doses of N4 and N1
(high:high) resulted in a reduced incidence of the N4 phenotype. Reducing the dose of N4 reduced the frequency of the phenotype (compare N4 [high] to N4 [low]).
A low dose of N4 plus a high dose of N1 also reduced the frequency of the low-dose N4 phenotype. Severity of phenotype was scored with *** being most severe.
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address the first possibility, we tested whether there was
increased proliferation in Noelin-4-expressing cells using the
mitosis marker anti-phospho-histone H3, which labels cells in
and shortly after metaphase (Saka and Smith, 2001).
Embryos were injected with Noelin-4 mRNA (500 pg) to
induce the neural expansion phenotype and examined for
alterations in cell division. At stage 14 and again at stage 24, no
evidence of increased mitosis was observed by phospho-Fig. 6. Ectoderm in Noelin-4 embryos is diverted toward a neural fate. (A–C) Meso
indicated isoform (N1 = Noelin-1, 500 pg; N4 = Noelin-4, 500 pg; N1 + N4 = 500 pg e
animal cap control). NCAM indicates neural induction, MA (muscle actin) indicates
affected by Noelin-1 over-expression. Neural plate stage embryos injected and stained
stage 16 (1 ng). Arrowheads indicate injected side. (D–G) Anti-phospho Histone H
difference in proliferation was observed. (D) Neural plate stage embryo, anterior to th
cells. (E–G) Stage 24 embryo. (E) Anterior to the left, injected side down. (F) Closeup
section (level of section indicated in panel E) with midline of embryomarked by vertic
which contains no extra proliferative figures. (H, I) Cell death assay ofNoelin-injected
4 (H, stage 17) or lacZ (I, stage 18). Anterior is oriented up. No change is noted in TUN
territory. Embryos injected with 1 ng Noelin-4 (J, stage 16) or Noelin-1 (K, stage 15) a
with dashed line; injected side is to the left (arrowheads). In panel J, note that the n
perturbed by Noelin-4 over-expression. Embryos were injected with 1 ng Noelin-4 an
embryo, Noelin-4-injected side is to the left (arrowhead). Note the loss of XSlug stain
Control side; (O) injected side; note missing streams of neural crest staining (brack
overgrown tissue outlined (arrowhead). (P) Cross section of a similar embryo showsm
formed byNoelin-4 ectopic expression (dashed outline) is negative for XTwist express
crest; e, eye; cg, cement gland; mb, midbrain.histone H3 staining (stage 14: n = 4, stage 23: n = 4 Figs. 6D, E)
either in whole mount or in sections by analyzing the number
of cells in metaphase (Figs. 6F, G). To determine whether a loss
of cell death might play a role in the expansion of neural fate in
Noelin-4-injected embryos, we examined them with TUNEL
staining. Noelin-4-injected embryos were indistinguishable by
TUNEL staining from control embryos, suggesting that there
was no decrease in cell death (Figs. 6H, I; n = 8 embryos per
condition).derm is not induced by Noelin-4. (A) RT-PCR of animal caps injected with the
ach; nog = 100 pg noggin; e = stage 22 embryo control; c = 500 pg lacZ-injected
mesoderm. EF1a is a loading control. (B, C) Mesodermal MA expression is not
forMA: (B) stage 15 embryo injected withNoelin-4 (1 ng); (C) Noelin-1 injected
3 staining of embryos injected with Noelin-4 (500 pg) and lacZ (50 pg). No
e left, injected side down. Brown dots indicate anti-phospho Histone H3 positive
of dorsal view (boxed area in panel E, midline marked by dashed line); (G) cross
al line. Note the expansion of tissue on injected side in panel F (below dotted line),
embryos. TUNEL staining of embryos injected in 2 of 2 cells with 500 pgNoelin-
EL staining between these embryos (n = 8 each). (J, K) Conversion of epidermal
nd stained for epidermal keratin. Neural plate territory and midline are indicated
eural plate remains larger on the injected side. (L–Q) Neural crest formation is
d stained for the neural crest marker XSlug (L, M) or XTwist (N–Q). (L) Stage 15
ing on the injected side. (M) Stage 16 embryo injected with Noelin-1 (BMZ). (N)
et) and overgrown tissue near neural tube (arrowhead). (Q) Dorsal view, with
andibular neural crest staining is missing from injected side (arrows). Extra tissue
ion. m, mandibular crest; h, hyoid crest, ba and bp: anterior and posterior branchial
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presumptive epidermis and neural crest
Another possible explanation for the observed expansion
of the nervous system is that it results from conversion of
other ectodermal cell fates (epidermal ectoderm and/or neural
crest) into neuroepithelium. In support of this possibility,
numerous islands of ectopic Sox-2-positive cells were
observed within the epidermal ectoderm (Figs. 5H–O).
Occasionally, these Sox-2-expressing regions in the epidermis
formed structures with the appearance of otic vesicles as
well as lateral extensions of the neural tube. When examined
in cross-section, these neural tissues appeared in the
epidermal ectoderm and were not associated with any
morphological indication of ectopic or mispatterned meso-
derm (Fig. 5J and data not shown). Furthermore, staining of
injected embryos with the epidermal marker epidermal
keratin (EK) revealed that the expanded neural plate
occupied territories that normally contain presumptive
epidermis, suggesting that the neural ectoderm in Noelin-4-
injected embryos expanded at the expense of the epidermal
ectoderm (Figs. 6J, K).
To examine how the ectoderm-derived neural crest was
affected after Noelin-4 over-expression, embryos were
analyzed with the neural crest markers XSlug (Mayor et
al., 1995) and XTwist (Hopwood et al., 1989). Noelin-4-Fig. 7. Noelin-4 binds to Noelin-1. (A) Noelin-4-myc and Noelin-1-flag constructs u
designated with a plus sign (+), or is without a tag when designated with a minus
immunoprecipitation assay in Xenopus oocytes. Oocytes were injected as indicated
with an untagged version of Noelin-1 and immunoprecipitated with either myc or fl
translated proteins (lanes 5, 6). Samples were immunoprecipitated with the indicat
Noelin-1-flag is indicated with arrows. (C) IP-Western blot. COS-7 cells were transf
or flag antibodies. Lysate (L) and supernatant (S) fractions were then resolved on SD
detection with the indicated antibody. Some of the precipitating antibodies were also
detected with the Western secondary antibody are indicated with asterisks in contro
with arrows. Myc pull-down of Noelin-4-myc samples brought down a band that im
pull-down on samples transfected with Noelin-1-flag and subsequently blotted for fl
with anti-myc contained flag-immunoreactive bands at the size of Noelin-1-flag (arinjected embryos exhibited reduced staining of both markers
on the injected side, and were sometimes missing individual
neural crest streams as assayed by XTwist staining (Figs.
6L–P, XTwist: n = 14/17; XSlug: n = 16/22). For example,
the hyoid and branchial neural crest streams typically were
absent (Fig. 6N), while the mandibular crest stream around
the eye was present but reduced in size (Figs. 6O, P). In
contrast, neural crest formation and migration appeared
normal in control embryos (XTwist: n = 17/17, XSlug 21/
22) and on the uninjected side of Noelin-4-injected embryos
(Figs. 6L–O). These results suggest that, in addition to epi-
dermal conversion, over-expression of Noelin-4 may divert
presumptive neural crest to neural fate.
Noelin-4 binds Noelin-1
Our previous studies on Noelin-1 suggested that it might
have binding partners either within the cell or in the
extracellular environment (Moreno and Bronner-Fraser,
2001). Under non-reducing gel conditions, Noelin-1 protein
(predicted size 56 kDa) ran as a band larger than 205 kDa.
We hypothesized that because of the similarities between
Noelin-1 and olfactomedin, a protein that forms multimers
in the extracellular matrix, Noelin-1 may also form multi-
mers with itself or other protein partners. Olfactomedin
multimerizes through a pair of cysteine residues (Yokoesed are shown diagrammatically. Noelin-1 bears an internal Flag epitope when
sign (). O, oocyte; IVT, in vitro-translated protein; m, myc; f, flag. (B) Co-
and cultured in the presence of 35S-methionine. Oocyte controls were injected
ag (lanes 1, 2). In vitro-translated proteins (lanes 3, 4) are compared to oocyte-
ed antibody (m = myc; f = flag). Noelin-4-myc is indicated with arrowheads;
ected with the indicated plasmids and then immunoprecipitated with either myc
S-PAGE and transferred to nitrocellulose before enhanced chemiluminescence
eluted during sample preparation; heavy and light-chain immunoglobulin bands
l lane 1. Noelin-4-myc is denoted with an arrowhead; Noelin-1-flag is denoted
munoreacted with myc on the Western blot (arrowhead, lanes 5, 6), as did flag
ag (lanes 7, 8). Samples transfected with both plasmids and immunoprecipitated
rows, lanes 9, 10).
Table 3
Noelin-3 acts similarly to Noelin-4 and is rescued by Noelin-1
Phenotype N3 N3 + N1 N4 N4 + N1 N1 lacZ
Enlarged/Ectopic
neural tissue
72% 32% 68% 21% 6% 0%
Severity ** * ** * * n/a
Number of embryos 36 47 44 39 35 38
Co-injection with Noelin-1 reduces the phenotype frequency for both Noelin-3
and Noelin-4. 1 ng Noelin-3 was injected with or without Noelin-1, in one cell
at the two cell stage. Noelin-4 was injected in one of two cells as in the low
dose experiment shown in Table 2, with or without Noelin-1. The phenotypes
counted in the scores include enlarged neural tissue, ectopic Sox-2 staining,
and ectopic cement gland, which were visualized at stage 31–33. N1 =
Noelin-1, N3 = Noelin-3, N4 = Noelin-4. The data represented here are from
one injection experiment; embryos exhibited combinations of the scored
phenotypes.
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isoforms.
To determine whether Noelin isoforms could interact, we co-
expressed differentially tagged Noelin-4 and Noelin-1 con-
structs and then immunoprecipitated with antibodies to the
different epitope tags. The Xenopus Noelin-4 construct contains
a carboxy terminal myc tag; this was co-expressed with a
Noelin-1 construct bearing an internal flag epitope (Fig. 7A).
Co-injected oocytes made proteins of the expected sizes for
both Noelin-4 and Noelin-1 (Fig. 7B, in vitro-translated
proteins lanes 3, 4). The results in Fig. 7 show that
immunoprecipitation of Noelin-4-myc co-precipitates a band
of the size of Noelin-1-flag, and vice versa. In oocyte fractions,
the greatest portion of immunoprecipitated Noelin-4 migrated
at approximately 22 kDa, with a weaker band found at about 11
kDa (Fig. 7B, lanes 5 and 6 Noelin-4 bands). Immunopreci-
pitated Noelin-1 ran at approximately 60 and 77 kDa for the
cellular and secreted forms, respectively (lanes 5 and 6;
(Moreno and Bronner-Fraser, 2001). The identity of these
bands was confirmed by immunoblot analysis against the
reciprocal proteins in tissue culture cells. Briefly, COS-7 cells
transfected with both Noelin-4-myc and Noelin-1-flag were
immunoprecipitated with either myc or flag antibody, followed
by Western blotting with the reciprocal antibody (Fig. 7C).
Pull-down with anti-myc antibody co-precipitated an anti-flag
reactive protein of the expected size for Noelin-1-flag (Fig. 7C,
lanes 9 and 10). Thus, we find that in Noelin-4 and Noelin-1
can form complexes in Xenopus oocyte and cell culture assay
systems.
Noelin-4 and Noelin-1 functionally interact
The biochemical results showing that Noelin-1 and Noelin-
4 can bind in cell-based assays suggested that they might
functionally interact in vivo. To test this, we co-injected
Noelin-4 and Noelin-1 mRNAs in varying ratios and then
examined the subsequent embryonic phenotypes. Interestingly,
the data show that Noelin-1 rescues the abnormalities caused
by Noelin-4 over-expression (Table 2), resulting in a marked
decrease in the percentage of embryos exhibiting defects.
Noelin-1 co-injection reduced the frequency of these pheno-
types approximately 3- to 8-fold. In contrast, Noelin-1 alone
caused no obvious morphological or gene expression pheno-
type (see Figs. 5B, Q, S, and 6C, K, M and Table 2). These
results indicate that in vivo, Noelins may interact and Noelin-1
may negatively regulate Noelin-4.
Noelin short isoforms have similar functions
With the exception of 30 additional amino acids in the
amino terminus, Noelin-3 and -4 share all structural features,
including the conserved cysteine residues in the M region, M
region glycosylation site and hyaluronate binding sites (see
Fig. 1A). Furthermore, Noelin-3 contains the same signal
peptide sequence (B region) that is cleaved to yield a secreted
protein in the case of Noelin-1 (Moreno and Bronner-Fraser,
2001). To test whether they had similar functions, we comparedthe effects of Noelin-3 over-expression in whole embryos to
that of Noelin-4. The over-expression phenotype of Noelin-3
was similar to that of Noelin-4 in these assays. 500 pg of
Noelin-3 mRNA microinjected into one blastomere at the 2-
cell stage gave rise to embryos exhibiting expansion of neural
tissue similar to that seen with Noelin-4. In the anterior neural
tube, expanded domains containing Sox-2-positive cells were
observed in neural tubes on the injected side (Fig. 5U). Over-
expression in the region of the eye caused enlarged retina
formation (Fig. 5T). These results suggest that Noelin-3 and
Noelin-4 function in like fashion.
To further test whether Noelin-3 might be functionally
similar to Noelin-4 in terms of the ability to be rescued by
Noelin-1, we again performed co-injection experiments.
Embryos exhibited a clear reduction in the neural expansion
phenotype when Noelin-1 was co-injected with Noelin-3, as
was the case for Noelin-4 and Noelin-1 co-expression (Table
3). Thus, the Y-form splice variants Noelin-3 and -4 have
similar activities. Taken together, these data suggest that
interacting Noelin isoforms may modulate one another’s
functions in vivo and promote certain fate choices depending
on the balance of these factors in the cell.
Discussion
Our characterization of Noelin-4 function in the early
Xenopus embryo suggests that it acts as a factor that
promotes neural precursor fate. Since over-expression of
Noelin-4 caused expansion of neural tissues but did not
induce ectopic neurogenesis, an endogenous function of this
glycoprotein may be to maintain neuronal precursors in a pre-
differentiated state until the appropriate time to continue
differentiation. The biochemical interaction of Noelin-4 with
Noelin-1 coupled with the ability of Noelin-1, a neurogenesis
promoting factor, to modulate this maintenance activity
suggest an interesting reciprocal mechanism by which the
balance of these family members in a differentiating cell
determines the precursor versus differentiated state. Our
results are also consistent with the possibility that Noelin-4
may titrate the neurogenesis-promoting effects of Noelin-1
until the appropriate time for differentiation to proceed. This
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bers of this family of secreted proteins may play a regulatory
role in modulating the timing of neuronal differentiation in
the early embryo.
Noelin-4 over-expression induces neural expansion
Excess Noelin-4 expression resulted in expansion of the
neural plate, later causing an array of phenotypes including
enlarged retinas and neural tubes, ectopic cement glands and
otic-like vesicles (see Table 1 and Fig. 5). Most of the tissue
expansion occurred in neural precursor cells as detected by
Sox-2 staining (Mizuseki et al., 1998b). This neural expansion
did not occur via increased proliferation or loss of cell death.
Instead, ectodermal tissues such as the cranial neural crest and
epidermis appeared to be reduced and replaced by ectopic Sox-
2-positive neural tissue in areas of Noelin-4 over-expression.
These results suggest that phenotypes observed with over-
expression of Noelin-4 are a conversion of non-neural or neural
crest fates toward a neural fate. Further support for this idea
comes from the presence of ectopic Sox-2-positive neural
structures in the epidermis at high doses of Noelin-4 (see Figs.
5 and 6N–P).
Noelin isoforms are induced by the neurogenic cascade
The timing of neuronal differentiation is an integral aspect
of nervous system development. In order for the proper
circuitry to form, neurons must be born and differentiate in a
specific manner and order. The bHLH transcription factors
neurogenin and NeuroD have neurogenic activity and play
important roles in neurogenesis in the early Xenopus embryo
(Brunet and Ghysen, 1999; Chang and Hemmati-Brivanlou,
1998). When NeuroD or neurogenin are expressed in the
epidermis, they cause ectopic differentiation of neurons therein
(Lee et al., 1995a; Ma et al., 1996). We previously showed that
ectopic expression of either X-ngnr-1 or XNeuroD induced
expression of Noelin-1/2 isoforms (Moreno and Bronner-
Fraser, 2001). In this study we show that Noelin-3/4 isoforms
are also induced by over-expression of these neurogenic genes
(Fig. 3). Because they are expressed in post-mitotic neurogenic
tissues, the finding that Noelin proteins can interact and modify
one another’s functions suggests a novel way for neuronal
differentiation to be regulated. Noelin-1 promotes earlier
neuronal differentiation in neuralized animal caps (Moreno
and Bronner-Fraser, 2001). This, coupled with our results
showing that Noelin-4 over-expression promotes neural plate
expansion (Sox-2) and a delay in neuronal marker expression
(N-tubulin), suggests that endogenously, Noelin proteins could
interact functionally and thereby regulate the timing of
differentiation in neuronal precursors.
Noelin functional domains
Our results here and in previous work suggest that two
separate functional domains reside in the Noelin proteins: a
neural expansion/maintenance activity that is found in the Mregion, and a differentiation activity that resides in the Z
region (Moreno and Bronner-Fraser, 2001). All Noelin
isoforms contain the M region but differ in their upstream
and downstream exons. The longer, Z-region-containing
isoforms Noelin-1 and -2 can promote neurogenesis, but
do not themselves act as neural maintenance factors. The
shorter, Y-containing isoforms, Noelin-3 and -4 act to
maintain and expand the neural precursor territory but do
not promote neuronal differentiation. Since the Y exon codes
for one glycine residue and then a stop, while at the amino
terminal, all of the A region and much of the B region are
cleaved during secretion, the Noelin-3/4 isoforms essentially
are composed of the M region. The Z region, which is large
(329 amino acids) and has five glycosylation sites (Barem-
baum et al., 2000; Moreno and Bronner-Fraser, 2001), may
act to block or sterically hinder the M region on the same
molecule. This could also explain why the Z isoforms do not
act as neural maintenance factors even though they contain the
common M region.
Noelin isoforms are expressed from neural plate stages
onward as assayed by RT-PCR (see Fig. 3). Later in
development, all isoforms are seen in post-mitotic neurogenic
tissues in the brain, spinal cord and cranial ganglia. The
expression profile of these isoforms is complicated by the fact
that the two Z-containing isoforms (Noelin-1 and -2) are made
by two different promoters, as are the two Y-containing
isoforms (Noelin-3 and -4); in other words, a Y- and a Z-
containing isoform are both transcribed from the same
promoter, so that whenever a cell transcribes Noelin-1
(BMZ), it also transcribes Noelin-3 (BMY). We observed no
differential regulation of the isoforms. Because of these
transcriptional and splicing properties of the Noelins, it is
difficult to examine the individual functions of Y-containing
(short) or Z-containing (long) isoforms in vivo with morpho-
lino antisense oligonucleotides since a long and a short form
share the same 5V exon.
Further levels of post-translation regulation, or of splicing
mechanisms and mRNA stability may play an important role in
modulating the expression levels of each isoform. Evidence for
this hypothesis comes from the chick system, where the Y-
containing isoforms are expressed later than the Z-containing
isoforms, even though both A and B promoters transcribe Y
and Z isoforms (Barembaum et al., 2000). This implies a level
of splicing or mRNA stability regulation that we have not
observed in Xenopus; however, it also suggests the existence of
an as-yet-unknown mechanism for specific regulation of splice
forms.
Noelin proteins interact and modulate partner function
The endogenous co-expression of Noelin isoforms suggests
that they could function together in vivo. Our data demonstrate
that Noelin isoforms biochemically bind to one another, since
even the shortest isoform, Noelin-4, can bind Noelin-1 in
immunoprecipitation assays. This suggests that the conserved
cysteine residues in the M region are responsible for
dimerization between Noelin isoforms as they are in olfacto-
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implications from the data regarding the different functional
domains of Noelin isoforms suggest that they may act as
cofactors in vivo.
We further showed that the activity of Noelin-4 in gain-
of-function experiments was modulated by co-expression of
Noelin-1. There are several possible mechanisms whereby
interaction between the isoforms could modulate their
activities. The large, Z-containing isoforms, which are
known to be rather poorly secreted (Moreno and Bronner-
Fraser, 2001), could act to restrict secretion of the Y-
containing isoforms by binding them in the endoplasmic
reticulum and thus preventing their efficient secretion. This
could regulate the neural maintenance effects of these
isoforms. Alternatively, the Z-containing isoforms, which
are highly glycosylated, could act as anchors in the
extracellular matrix for the smaller Y-containing isoforms,
to maintain them in a specific area instead of allowing them
to disperse. This could provide a local concentration for the
Y isoforms to exert their effects. Moreover, these two
proposed mechanisms could operate in concert, with the Z
isoforms slowing the secretion of the Y isoforms, and then
maintaining them in a local area for further activity. Our
over-expression experiments may have disrupted the balance
of the in vivo ratio of Y and Z, allowing this gain-of-
function phenotype to be revealed.
Other olfactomedin family proteins modulate each other’s
functions
An important structural feature of the Noelin proteins is
the olfactomedin domain. This region, contained in the C-
terminal of the Noelin-1 and -2 isoforms, is related to similar
domains in several proteins: MYOC/TIGR, a secreted protein
in the aqueous humor of the vertebrate eye (Kubota et al.,
1997); optimedin, also found in the vertebrate eye (Torrado et
al., 2002); olfactomedin, a major protein in the extracellular
matrix of the olfactory epithelium (Snyder et al., 1991);
tiarin, a dorsalizing factor in Xenopus embryos (Tsuda et al.,
2002); and amassin, a secreted protein responsible for
clotting of coelomocytes in the sea urchin (Hillier and
Vacquier, 2003).
The olfactomedin domain is responsible for formation of
oligomers of olfactomedin (Snyder et al., 1991) and of amassin
(Hillier and Vacquier, 2003). However, olfactomedin-related
proteins associate by other means as well. In MYOC, homo-
protein interaction occurs via the more N-terminal leucine
zipper domain (Fautsch and Johnson, 2001), but the olfacto-
medin domain is necessary for proper protein folding and
secretion, as well as interaction with other proteins (Caballero
and Borras, 2001; Caballero et al., 2000; Gobeil et al., 2004).
Our results demonstrate that Noelins-1 and -4 interact
biochemically even though Noelin-4 does not contain an
olfactomedin domain. This interaction may occur through
disulfide bridges between the two conserved cysteine residues
in the M region. These residues are homologous to cysteine
residues found in olfactomedin, MYOC, tiarin and amassin,and are outside of the olfactomedin domain in all of these
proteins (see Hillier and Vacquier, 2003).
An intriguing analogy to our findings regarding the
interaction between Noelin-1 and Noelin-4 exists in the
vertebrate eye. MYOC, which is mutated in some forms of
primary open angle glaucoma, interacts with optimedin in co-
immunoprecipitation assays. In transfected cells, mutant
MYOC interferes with secretion of optimedin, causing it to
be sequestered in the endoplasmic reticulum (Torrado et al.,
2002). These results are significant because they provide
another example of olfactomedin-related proteins binding to
each other in a manner that affects each other’s function. In
the present case, over-expression of Noelin-4 causes over-
growth of the neural plate territory leading to several
mispatterning anomalies in the later embryo. However, co-
expression of Noelin-1, which binds to Noelin-4, strongly
reduces this activity.
The ability of Noelin-1 and -4 to bind does not rule out the
possibility that Noelins may interact with other proteins. Good
candidates for such an interaction are other olfactomedin-
domain proteins. Strikingly, Xenopus tiarin is expressed in
tissues adjacent to Noelin-expressing tissues during early
development (Moreno and Bronner-Fraser, 2001; Tsuda et
al., 2002). Tiarin over-expression causes a dorsalized pheno-
type, with expansion of dorsal markers in the neural tube and
loss of ventral marker expression, while Noelin-4 over-
expression causes expansion of the neural territory. One
possibility is that these two proteins may interact in vivo such
that Noelin-4 potentiates the function of tiarin. The emerging
hypothesis is that interaction of olfactomedin-domain proteins
may result in modifications of their cellular localization and
function.
Our data uncover a novel role for Noelins in balancing the
timing of neuronal differentiation. Several lines of evidence
support the possibility that interactions between Noelins may
influence this timing. First, Noelin-1 over-expression in
neuralized animal caps promotes neuronal differentiation at
an earlier stage (Moreno and Bronner-Fraser, 2001). Second,
Noelin-4 neural expansion activity is often accompanied by a
delay in expression of the neuronal differentiation marker, N-
tubulin. Third, Noelin-1 rescues the neural precursor expan-
sion phenotype of Noelin-4. Certainly, the picture is more
complicated than these two factors alone determining the
timing of differentiation. Noelin expression is robust only
after neurons become postmitotic, and in fact are induced by
neurogenic genes like XNeuroD and X-ngnr-1. Additionally,
in gain-of-function experiments, Noelins act downstream of
early inductive events; for example, Noelin-1 only promotes
premature neuronal differentiation in neuralized animal caps,
but not in whole embryos. Similarly, Noelin-4 can alter
neural precursor fate only in tissues contiguous with
endogenous neural tissue, suggesting that it promotes this
fate in non-neural tissue that may have been exposed to
neuralizing signals rather than acting as an inducer itself. In
this regard, it does not induce neural fate in ventral ectoderm.
This implies that Noelins require other cofactors or certain
cellular contexts to exert these functions. In cells that
T.A. Moreno, M. Bronner-Fraser / Developmental Biology 288 (2005) 434–447446endogenously express Noelins, differential regulation of
Noelin isoform levels or activity may result in modulation
of neural precursors between undifferentiated and differenti-
ated states.
Note added in proof
A recent publication by Ando and colleagues investigated
the biochemistry of mouse Pancortin-3 (Noelin-2) and presents
results consistent with our findings in Xenopus. On Western
blots, they find evidence that all four Pancortins multimerize,
and show specifically that Pancortin-3 forms oligomers. In
addition, the two conserved cysteine residues in the common M
region were found to be necessary for multimerization and
secretion of Pancortin-3 (Ando et al., 2005).
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